major hex on this stockFYI this am...
'Valeant Pharmaceuticals International said on Friday U.S. regulators have raised concerns over a new eye drop manufactured at a Bausch + Lomb facility in Florida.
The U.S. Food and Drug Administration, in a complete response letter (CRL) regarding the eye drop for a type of glaucoma, raised concerns over Current Good Manufacturing Practice at the unit.
The letter did not identify any efficacy or safety issues with the eye drop, a latanoprostene bunod ophthalmic solution.
Valeant said it intends to meet the regulators and resolve these concerns, the company said in a statement.'
Someone has cast a major spell against this stock!!!
carlos